Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 7, 2015

View Archived Issues

Modified cobratoxin RPI-78M granted U.S. orphan status for pediatric multiple sclerosis

Ex scientia delivers first compound in Sumitomo Dainippon collaboration

Incyte and Jiangsu Hengrui Medicine sign global license agreement for SHR-120

Novimmune and Baxalta form collaboration to discover bispecific antibodies

Redx and Horizon Discovery establish cancer research collaboration

Department of Defense awards Cleveland BioLabs contract for development of entolimod

Prostate tissue accumulation inconsistent with absorption-enhanced formulation of DIM

Dose-response effects described for encenicline in schizophrenia

Patupilone active against brain metastases from non-small cell lung cancer

Cellsight Technologies PET tracer [18F]F-AraG first-in-human results are positive

FORUM Pharmaceuticals describes PDE9A inhibitors that may improve cognition

Daiichi Sankyo discloses RuvB-like 1/RuvB-like 2 complex ATPase inhibitors

Bionomics presents new VEGFR-3/FAK inhibitors

Novartis' Farydak receives E.U. approval for multiple myeloma

Achillion discovers complement factor D inhibitors

Boehringer Ingelheim discloses neutrophil elastase inhibitors

Bristol-Myers Squibb introduces HIV integrase inhibitors

FDA extends PDUFA date for Kanuma

Relief Therapeutics licenses atexakin alfa rights from Merck Serono

FDA grants priority review to daratumumab BLA for multiple myeloma

Allergan to acquire ocular device company AqueSys

FDA approves Xuriden for hereditary orotic aciduria

Terumo's autologous skeletal myoblast sheets approved in Japan for heart failure

Audentes Therapeutics acquires Cardiogen Sciences

Glenmark completes phase I studies for GBR-830

Exploratory trial of SAGE-547 in essential tremor shows significant reduction in tremor

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...